Results 191 to 200 of about 91,972 (285)
Unsatisfactory outcomes in myasthenia gravis: influence by care providers [PDF]
Myasthenia gravis (MG) can be difficult to treat despite an available therapeutic armamentarium. Our aim was to analyze the factors leading to unsatisfactory outcome (UO).
Borruat, François-Xavier+5 more
core
ABSTRACT Introduction/Aims Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a potentially disabling autoimmune neuropathy. Approximately 20% of patients are refractory to first‐line treatments necessitating second‐line options with limited evidence and potential adverse effects.
Shamim Miah+6 more
wiley +1 more source
Thyrotoxicosis, Exophthalmic Ophthalmoplegia, Myasthenia Gravis and Vitiligo
Raymond Greene
openalex +1 more source
ABSTRACT Introduction/Aims The Adverse Event Unit (AEU) is a patient and physician weighted unit that quantifies and compares adverse event (AE) burden among any neurologic treatments. A recent study demonstrated feasibility and preliminary validity of the AEU in myasthenia gravis (MG).
Michael K. Hehir+2 more
wiley +1 more source
Ophthalmoplegia as Sole Manifestation of Myasthenia Gravis over Twenty-Five Years [PDF]
C. J. Gavey
openalex +1 more source
Abstract Respiratory acidosis and alkalosis are two of the four main acid‐base processes encountered in clinical practice. These two processes are tightly balanced by breathing. Identification and management of respiratory acid‐base disorders are important for clinicians, particularly when caring for patients with underlying pulmonary and neurological ...
Anne M. Tucker, Tami N. Johnson
wiley +1 more source
Вивчення якості життя та тривожності у хворих на міастенію (клініко-параклінічні співставлення) [PDF]
У статті представлено результати дослідження тривожності та якості життя у 96 хворих на міастенію в залежності від імунологічного типу, тривалості та клінічної форми захворювання.
Кальбус, О.І.
core
Myasthenia Gravis and Pregnancy [PDF]
Fraser D, Turner Jw
openaire +5 more sources